Genistein prevents isoproterenol-induced cardiac hypertrophy in rats

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 8, 2012, Pages 1117-1125

  Maulik, Subir Kumar ^a   Prabhakar, Pankaj ^a   Dinda, Amit Kumar ^a   Seth, Sandeep ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cardiac hypertrophy; Fibrosis; Genistein; Myocyte size; Nitric oxide; NOS inhibitor; Oxidative stress

Indexed keywords

CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENISTEIN; GLUTATHIONE; HYDROXYPROLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; CARDIOMEGALY; CARDIOTONIC AGENTS; CATALASE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FIBROSIS; GENISTEIN; GLUTATHIONE; GUANIDINES; HYDROXYPROLINE; ISOPROTERENOL; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84864222435     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-068     Document Type: Article

References (40)

1. Aebi, H. 1974. Catalase. In Methods of enzymatic analysis. 3rd ed. Edited by H.U. Bergmeyer. Verl. Chemie/Academic Press Inc. pp. 673-685.
2. Anderson, J.W., Smith, B.M., and Washnock, C.S. 1999. Cardiovascular and renal benefits of dry bean and soybean intake. Am. J. Clin. Nutr. 70(3 Suppl.): 464S-474S. PMID:10479219.
3. Assayag, P.F., Carré, F., Chevalier, B., Delcayre, C., Mansier, P., and Swynghedauw, B. 1997. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc. Res. 34(3): 439-444. doi:10.1016/S0008-6363(97) 00073-4. PMID:9231026.
4. Benjamin, I.J., Jalil, J.E., Tan, L.B., Cho, K., Weber, K.T., and Clark, W.A. 1989. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65(3): 657-670. PMID:2527639.
5. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72(1-2): 248-254. doi:10.1016/0003-2697(76)90527-3. PMID:942051.
6. Brindicci, C., Ito, K., Torre, O., Barnes, P.J., and Kharitonov, S.A. 2009. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, ealthy smokers, and COPD patients. Chest, 135(2): 353-367. doi:10.1378/chest.08-0964. PMID: 18719059.
7. Cheng, T.H., Cheng, P.Y., Shih, N.L., Chen, I.B., Wang, D.L., and Chen, J.J. 2003. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 42(10): 1845-1854. doi:10.1016/j.jacc.2003.06.010. PMID:14642698.
8. Chiariello, M., Ambrosio, G., Cappelli, B.M., Perrone, F.P., Brigante, F., and Sifola, C. 1986. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J. Mol. Cell. Cardiol. 18(3): 283-290. doi:10.1016/S0022-2828(86)80410-2. PMID:3083110.
9. Corbett, J.A., and McDaniel, M.L. 1996. The use of Aminoguanidine, a selective iNOS inhibitor, to evaluate the role of nitric oxide in the development of autoimmune diabetes. Methods, 10(1): 21-30. doi:10.1006/meth.1996.0074. PMID:8812641.
10. Cuspidi, C., Ciulla, M., and Zanchetti, A. 2006. Hypertensive myocardial fibrosis. Nephrol. Dial. Transplant. 21(1): 20-23. doi:10.1093/ndt/gfi237. PMID:16263734.
11. Dhalla, A.K., Hill, M.F., and Singal, P.K. 1996. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28(2): 506-514. doi:10.1016/0735-1097(96)00140-4. PMID:8800132.
12. Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82(1): 70-77. doi:10.1016/0003-9861(59)90090-6. PMID:13650640.
13. Giardino, I., Fard, A.K., Hatchell, D.L., and Brownlee, M. 1998. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes, 47(7): 1114-1120. doi:10.2337/diabetes.47.7.1114. PMID:9648836.
14. Gomes Pessanha, M., Mandarim-de-Lacerda, C.A., and Dumas Hahn, M. 1999. Stereology and immunohistochemistry of the myocardium in experimental hypertension: long-term and low-dosage administration of inhibitor of the nitric oxide synthesis. Pathobiology, 67(1): 26-33. doi:10.1159/000028047. PMID:9873225.
15. Homma, N., Morio, Y., Takahashi, H., Yamamoto, A., Suzuki, T., Sato, K., et al. 2006. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension. Respiration, 73 (1): 105-112. doi:10.1159/000088946. PMID:16432296.
16. Iaccarino, G., Dolber, P.C., Lefkowitz, R.J., and Koch, W.J. 1999. Beta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by b-but not a1-adrenergic stimulation. Hypertension, 33(1): 396-401. PMID:9931136.
17. Jaiswal, A., Kumar, S., Enjamoori, R., Sandeep, S., Dinda, A.K., and Maulik, S.K. 2010. Peripheral benzodiazepine receptor ligand Ro5-4864 inhibits isoprenaline-induced cardiac hypertrophy in rats. Eur. J. Pharmacol. 644(1-3): 146-153. doi:10.1016/j.ejphar. 2010.06.058. PMID:20621082.
18. Kakkar, P., Das, B., and Viswanathan, P.N. 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21(2): 130-132. PMID:6490072.
19. Kumar, S., Enjamoori, R., Jaiswal, A., Ray, R., Seth, S., and Maulik, S.K. 2009a. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J. Pharm. Pharmacol. 61(11): 1529-1536. PMID:19903379.
20. Kumar, S., Seth, S., Jaiswal, A., Enjamoori, R., Dinda, A.K., Ray, R., and Maulik, S.K. 2009b. Chronic beta-adrenergic activationinduced left ventricular systolic dysfunction is associated with systemic release of TNF-a and IL-1b in rats. Pharmacol. Rep. 61 (5): 870-876. PMID:19904010.
21. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., et al. (Chamber Quantification Writing Group and American Society of Echocardiography's Guidelines and Standards CommitteeEuropean Association of Echocardiography). 2005. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18(12): 1440-1463. doi:10. 1016/j.echo.2005.10.005. PMID:16376782.
22. Lee, J.S. 2006. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci. 79(16): 1578-1584. doi:10.1016/j. lfs.2006.06.030. PMID:16831449.
23. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., and Castelli, W.P. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322(22): 1561-1566. doi:10.1056/NEJM199005313222203. PMID:2139921.
24. L-Arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Basic Clin. Pharmacol. Toxicol. 103(2): 124-130. doi:10.1111/j.1742-7843. 2008.00261.x. PMID:18816294.
25. Litwin, S.E., Katz, S.E., Weinberg, E.O., Lorell, B.H., Aurigemma, G.P., and Douglas, P.S. 1995. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation, 91(10): 2642-2654. PMID:7743628.
26. Loyer, X., Heymes, C., and Samuel, J.L. 2008. Constitutive nitric oxide synthases in the heart from hypertrophy to failure. Clin. Exp. Pharmacol. Physiol. 35(4): 483-488. doi:10.1111/j.1440-1681. 2008.04901.x. PMID:18307746.
27. Massion, P.B., and Balligand, J.L. 2007. Relevance of nitric oxide for myocardial remodeling. Curr. Heart Fail. Rep. 4(1): 18-25. doi:10. 1007/s11897-007-0021-6. PMID:17386181.
28. NIH. 1985. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23, Ed. revised 1985. National Academies Press, Washington, D.C. Latest edition available from oacu. od. nih. gov/regs/guide/guide. pdf
29. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95(2): 351-358. doi:10.1016/0003-2697(79)90738-3. PMID: 36810.
30. Park, C.E., Yun, H., Lee, E.B., Min, B.I., Bae, H., Choe, W., et al. 2010. The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J. Med. Food, 13(4): 815-820. doi:10.1089/jmf.2009.1359. PMID:20673057.
31. Penna, C., Mancardi, D., Rastaldo, R., and Pagliaro, P. 2009. Cardioprotection: a radical view free radicals in pre and postconditioning. Biochim. Biophys. Acta, 1787(7): 781-793.
32. Sacks, F.M., Lichtenstein, A., Van Horn, L., Harris, W., Kris-Etherton, P., and Winston, M. American Heart Association Nutrition Committee. 2006. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, 113(7): 1034-1044. doi:10.1161/CIRCULATIONAHA.106.171052. PMID:16418439.
33. Schlaich, M.P., Kaye, D.M., Lambert, E., Sommerville, M., Socratous, F., and Esler, M.D. 2003. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation, 108(5): 560-565. doi:10.1161/01.CIR.0000081775. 72651.B6. PMID:12847071.
34. Shimizu, H., Ross, R.K., Bernstein, L., Yatani, R., Henderson, B.E., and Mack, T.M. 1991. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer, 63(6): 963-966. doi:10.1038/bjc.1991.210. PMID: 2069852.
35. Umar, S., and van der Laarse, A. 2010. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol. Cell. Biochem. 333(1-2): 191-201. doi:10.1007/s11010-009-0219-x. PMID:19618122.
36. Valsecchi, A.E., Franchi, S., Panerai, A.E., Rossi, A., Sacerdote, P., and Colleoni, M. 2011. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur. J. Pharmacol. 650(2-3): 694-702. doi:10.1016/j.ejphar.2010.10. 060. PMID:21050844.
37. Weber, K.T. 2000. Fibrosis and hypertensive heart disease. Curr. Opin. Cardiol. 15(4): 264-272. doi:10.1097/00001573-200007000-00010. PMID:11139090.
38. Weber, K.T., Brilla, C.G., and Janicki, J.S. 1993. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 27 (3): 341-348. doi:10.1093/cvr/27.3.341. PMID:8490934.
39. Zhang, G.X., Kimura, S., Nishiyama, A., Shokoji, T., Rahman, M., Yao, L., et al. 2005. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc. Res. 65(1): 230-238. doi:10.1016/j.cardiores.2004.08.013. PMID:15621051.
40. Zhang, P., Xu, X., Hu, X., Van Deel, E.D., Zhu, G., and Chen, Y. 2007. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ. Res. 100(7): 1089-1098. doi:10. 1161/01.RES.0000264081.78659.45. PMID:17363700.